Skip to Content

Curosurf Side Effects

Generic Name: poractant

Note: This page contains information about the side effects of poractant. Some of the dosage forms included on this document may not apply to the brand name Curosurf.

Not all side effects for Curosurf may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to poractant: intratracheal suspension

Side effects include:

Transient bradycardia, hypotension, endotracheal tube blockage, decreased oxygen saturation.

For Healthcare Professionals

Applies to poractant: intratracheal suspension

General

Transient adverse effects include bradycardia, hypotension, endotracheal tube blockage and oxygen desaturation.[Ref]

Cardiovascular

Very common (10% or more): Patent ductus arteriosus (up to 60%) in premature infants
Rare (less than 0.1%): Bradycardia, hypotension[Ref]

Patent ductus arteriosus has also been reported with other exogenous surfactants and is attributed to hemodynamic changes induced by the rapid expansion of the lungs with surfactant administration.[Ref]

Other

Very common (10% or more): Acquired pneumonia (up to 17%) and septicemia (14%) in premature infants
Uncommon (0.1% to 1%): Sepsis[Ref]

Nervous system

Very common (10% or more): Intracranial hemorrhage (up to 51%) in premature infants
Uncommon (0.1% to 1%): Intracranial hemorrhage
Frequency not reported: Abnormal electroencephalogram[Ref]

The occurrence of intracranial hemorrhages after instillation of this drug has been related to the reduction in mean arterial blood pressure and early peaks in arterial oxygenation (PaO2). High PaO2 peaks by ventilator adjustment immediately after instillation should be avoided.
Preterm newborns have relatively high incidences of cerebral hemorrhages and cerebral ischemia, reported as periventricular leukomalacia and hemodynamic anomalies such as patent ductus arteriosus and persistence of fetal circulation despite the provision of intensive care.
Seizures may also occur in the perinatal period.[Ref]

Respiratory

Very common (10% or more): In premature infants: Pulmonary interstitial emphysema (up to 23%), pneumothorax (up to 21%), bronchopulmonary dysplasia (up to 18%)
Uncommon (0.1% to 1%): Pneumothorax
Rare (less than 0.1%): Bronchopulmonary dysplasia, decreased oxygen saturation
Frequency not reported: Hyperoxia, cyanosis neonatal, apnea, endotracheal intubation complication
Postmarketing reports: Pulmonary hemorrhage (known complication of premature birth and very low birth)[Ref]

Apnea and sepsis may occur as consequences of the immaturity of the infants.
Preterm babies commonly develop hematological and electrolyte disorders which may be worsened by severe illness and mechanical ventilation. Other complications of prematurity, including the following disorders directly related to illness severity and use of mechanical ventilation necessary for reoxygenation, may also occur: Pneumothorax, interstitial pulmonary emphysema and pulmonary hemorrhage. The prolonged use of high concentrations of oxygen and mechanical ventilation are associated with the development of bronchopulmonary dysplasia and retinopathy of prematurity.[Ref]

References

1. "Product Information. Curosurf (poractant)" Dey Laboratories, Napa, CA.

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

3. Cerner Multum, Inc. "Australian Product Information." O 0

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide